Long-term exposure to fine particulate matter and incidence of esophageal cancer: a prospective study of 0.5 million Chinese adults.
Sun D. et al, (2023), Gastroenterology
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial.
Parish S. et al, (2023), Trials, 24
Diabetes and infectious disease mortality in Mexico City.
Bragg F. et al, (2023), BMJ Open Diabetes Res Care, 11
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.
Zhou J. et al, (2023), Pharmacoeconomics
Mechanisms and Predictors of Acute Kidney Injury with Perioperative Rosuvastatin in Patients Undergoing Cardiac Surgery
Wijesurendra RS. et al, (2023)
Body Composition and Risk of Vascular-Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease.
Gnatiuc Friedrichs L. et al, (2023), J Am Heart Assoc
Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults.
Clarke R. et al, (2023), Hypertension
Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.
Bowman L. et al, (2022), Circulation
Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study.
Chan KH. et al, (2022), Lancet Public Health, 7, e1014 - e1026
UK Biobank: a globally important resource for cancer research.
Conroy MC. et al, (2022), Br J Cancer
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes.
Nag A. et al, (2022), Sci Adv, 8
Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults.
Aguilar-Ramirez D. et al, (2022), Commun Med (Lond), 2
How UK Biobank is democratising access to large-scale genomic and phenotypic data for discovery science
LACEY B. et al, (2022)
Stroke genetics informs drug discovery and risk prediction across ancestries.
Mishra A. et al, (2022), Nature
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 645 - 654
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.
Akbari P. et al, (2022), Nat Commun, 13
New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders.
Bešević J. et al, (2022), J Clin Endocrinol Metab, 107, 2403 - 2410
Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy
BAIGENT C. et al, (2022), The Lancet
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.
Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials